Skandinaviska Enskilda Banken Ab (Publ) Atri Cure, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $141,857 - $185,975	4,300 Added 32.58%	17,500 $624,000
Q3 2023 Nov 09, 2023	BUY	$41.12 - $57.73 $8,224 - $11,546	200 Added 1.54%	13,200 $578,000
Q2 2023 Aug 07, 2023	SELL	$40.44 - $49.6 $121,320 - $148,800	-3,000 Reduced 18.75%	13,000 $642,000
Q1 2023 May 11, 2023	BUY	$35.87 - $47.22 $573,920 - $755,520	16,000 New	16,000 $663,000
Q2 2021 Aug 10, 2021	SELL	$64.13 - $80.18 $519,452 - $649,458	-8,100 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$34.56 - $57.55 $86,400 - $143,875	2,500 Added 44.64%	8,100 $451,000
Q3 2020 Nov 12, 2020	BUY	$38.36 - $46.91 $214,816 - $262,696	5,600 New	5,600 $223,000

212

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.85B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.